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Abstract One of the goals of medical research in the area of dementia is to correlate
images of the brain with clinical tests. Our approach is to start with the images and explain
the differences and commonalities in terms of the other variables. First, we cluster Positron
emission tomography (PET) scans of patients to form groups sharing similar features in brain
metabolism. To the best of our knowledge, it is the first time ever that clustering is applied
to whole PET scans. Second, we explain the clusters by relating them to non-image vari-
ables. To do so, we employ RSD, an algorithm for relational subgroup discovery, with the
cluster membership of patients as target variable. Our results enable interesting interpreta-
tions of differences in brain metabolism in terms of demographic and clinical variables. The
approach was implemented and tested on an exceptionally large data collection of patients
with different types of dementia. It comprises 10 GB of image data from 454 PET scans,
and 42 variables from psychological and demographical data organized in 11 relations of a
relational database. We believe that explaining medical images in terms of other variables
(patient records, demographic information, etc.) is a challenging new and rewarding area for
data mining research.
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1 Introduction
Every year, 200,000 people are diagnosed with some type of dementia in Germany and 40%
of them with Alzheimer’s disease [1]. Due to the “aging society”, this figure is expected
to increase continuously over the next decades. Although some forms of dementia like
Alzheimer’s disease are well-known and characterized for one 100 years now, the under-
lying mechanisms are still not sufficiently understood. Therefore, there is great interest in
expanding our knowledge of various forms of dementia, including Alzheimer’s disease.
Generally speaking, the symptoms of Alzheimer’s disease are caused by the deposition
of pathological proteins in the form of intracellular tangles and extracellular plaques. This
deposition is followed by neuron death and deficits in neurotransmitter systems. Further-
more, deficits in glucose metabolism occur, which can be assessed in-vivo by [18] F-FDG
Positron-Emission-Tomography (FDG-PET) to detect regional functional pathology.
Given the results from such neuroimaging studies, one of the major goals of medi-
cal research is to correlate them with other non-image based variables (e.g., demographic
information or clinical data). The usual approach is to select a subset of patients fulfilling
specific predefined criteria (e.g., the level of cognitive impairment) and to compare the images
associated with those patients to data from healthy controls in a group analysis. However,
it is clear that such an approach can never be guaranteed to be complete: If the first step
misses an important subset, it is not possible to recover from this omission in subsequent
steps.
Therefore, we propose to apply data mining techniques to take the opposite approach: to
start with the images and explain the differences and commonalities in terms of non-image
variables. In this way, the results of the analysis are less dependent on the choices made
in the selection of patients. In fact, the goal is to obtain a complete list of descriptions of
subgroups of patients, which are unusual with respect to the Positron emission tomography
(PET) images. The approach was implemented and tested on data derived from an exception-
ally large pre-existing data collection of patients with different types of dementia, collected
at our university hospital. In the first step, we clustered FDG-PET scans of patients to form
groups sharing similar features in brain metabolism. In the second step, we explained the
clusters by relating them to clinical and other non-image variables. To do so, we employed
RSD [10,17], an algorithm for relational subgroup discovery, with the cluster membership
of patients as the target variable. After extracting relevant information from 200 GB of data
(removing duplicates, intermediate results, and incompletely processed images), we obtained
a dataset comprising 10 GB of image data from 454 PETs, and 42 variables from clinical
and demographical data organized in 11 relations of a relational database. Large image clus-
ters identified metabolic patterns corresponding well to typical findings in major types of
dementia. Furthermore, the approach allowed the detection of differences in cognitive per-
formance in presence of comparable brain pathology, thus potentially helping to identify
factors supporting compensation (e.g., age, gender, education).
In summary, the contributions of the paper are as follows: First, we present a new appli-
cation area and task for data mining in a highly relevant area of medical research. Second,
we present the first clustering of whole PET scans. Third, we propose, motivated by medical
considerations, a new type of correlation analysis based on a loose coupling of clustering and
subgroup discovery. Fourth, the procedure itself is novel in the medical area, as the approach
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is diametral to current practice in the analysis of PET images and deemed highly relevant by
medical experts in the field.
This paper is organized as follows: We start with a description of the data set including the
preprocessing steps (Sect. 2). In Sect. 3, we subsequently explain our workflow and how we
applied the clustering and subgroup discovery algorithms to the data set. Section 4 presents
our results and their interpretation by medical experts. In Sect. 5, we compare our approach
to itemset constrained clustering. Section 6 discusses the results from a higher perspective.
The paper closes with a review of related work (Sect. 7) and the overall conclusion.
2 Dementia data
The data were provided by the psychiatry and nuclear medicine departments of Klinikum
rechts der Isar of Technische Universität München. It consists of demographic information,
clinical data, including neuropsychological test results, and PET scans showing the patient’s
cerebral glucose metabolism. We had access to clinical and demographic data of 4,037 patient
visits and 454 PET scans that have been collected between 1995 and 2006.
To increase the quality of the data, we revised the existing psychological data of the 1,100
visits of patients having a corresponding PET or cerebrospinal fluid examination (test for cer-
tain protein levels). Our revision included the correction of typing errors and the completion
of electronically available test results. For some patients with PET, a revision was not possible
due to missing patient records. 257 PETs belong to patients with revised psychological and
demographic values. The overall effort for revising the data was approximately four person
months.
2.1 Positron emission tomography
Positron emission tomography is a non-invasive medical imaging procedure that has been
used for diagnostics of dementia since the early eighties. It displays a three-dimensional map
of the glucose metabolisms of the body and is based on the decay of radioactive markers,
which are injected into the patient. A scanner records the cell activation, and a computer
calculates the three-dimensional image of the metabolism. The recorded PETs in this study
indicate the metabolism of the brain, i.e., the transformation of glucose. This reflects the
activity of neural cells. The brain of patients suffering from dementia contains regions where
the metabolism is clearly lowered. In Alzheimer’s disease, the pattern of hypometabolism
starts at the hippocampus and spreads over the entire cortex as the disease progresses, sparing
few areas such as the motor and primary visual cortices.
Before physicians can actually use the PET scans, the images have to be processed by a
sequence of transformation steps. The image preprocessing pipeline of our study is illustrated
in the upper left-hand part of Fig. 1. Due to measurement irregularities and the motion of
patients during the recording of the images, each image has to be rotated and translated, such
that they all fit into the same template. This is achieved by SPM5.1 Subsequently, the images
are forwarded to (X)MedCon,2 which transforms the data into raw ASCII files representing
the intensity of each voxel as a real value. The last step is the normalization by dividing each
voxel value by the mean voxel value of the image. At the end of the preprocessing, each file
consists of 69 matrices of 79 rows and 96 columns, summing up to 523,296 voxels. Each
1 SPM5 release 1 December 2005, based on Matlab 7.3, see http://www.fil.ion.ucl.ac.uk/spm/software/spm5/.
2 XMedcon 0.9.9.3, http://xmedcon.sourceforge.net/.
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Fig. 1 Workflow of our approach. The upper part shows the processing of image data, the lower part the pro-
cessing of the structured non-image data. Preprocessing steps are on the left side, data mining and interpretation
of results on the right
Fig. 2 Mean image of 20 healthy
controls
of the 69 layers reflects a horizontal cut through the brain, presenting a two-dimensional
image of the layer with voxels displaying the intensity of metabolism of the corresponding
region.
In order to visualize a group of scans, we computed a mean image using SPM5. In a mean
image, each voxel contains the mean voxel value at that position. The mean image has the
advantage of showing the overall properties of a group. Note that each mean image shown in
this paper displays only one layer of the three-dimensional mean image. We always choose
the same layer (layer 32) to facilitate a comparison of the images. However, for the evaluation
of clusters, we take into account all 69 layers.
Figure 2 shows the mean image of 20 healthy controls. The “north” displays the frontal
region of the brain from an top-down view. The lighter the spots, the more active is the under-
lying tissue. Both sides of the brain are symmetric in their metabolism. The lateral regions
have an increased metabolism, while the center has lower metabolism. This is due to the fact
that the brain cells are residing in the outer areas of the brain, whereas the brain center mostly
consists of dendrites.
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2.2 Demographic data
We had access to demographic data of 4,037 patient visits (751 with revised data). The data
covers gender, age, years of education, type of graduation and profession.
2.3 Neuropsychological data
The clinical data for each patient consist of both psychological test results and information
about which of the other tests (e.g., MRI, CT, SPECT and EEG) were completed during a
hospital visit. Additionally, the diagnosis for each visit is provided in the form of ICD-10
codes [19].
The assessment instruments are the standard tests to diagnose dementia: Consortium
to Establish a Registry for Alzheimer’s Disease Neuropsychological Assessment Battery
(CERAD), Clinical Dementia Rating (CDR), and the clock-drawing test CDT. These tests
are optionally done at each patient visit at the physician’s discretion.
The CERAD test consists of eight subtests which evaluate the patient’s cognitive abilities
in the areas of semantic memory, word finding, visual cognition, orientation, concentra-
tion, direct retentiveness, visuo-construction, and delayed retentiveness. These eight sub-
tests are called verbal fluency (achievable score: 0–∞), Boston Naming Test (BNT) (0–15),
Mini-Mental-State Examination (MMSE) (0–30), word list learning (0–30), constructional
praxis (0–11), word list recall (0–10), word list recognition (0–20) and constructional praxis
recall (0–11). The healthier a person, the more points are expected. It is possible to cal-
culate a score (0–100) over all CERAD subtests [3]. This score was also integrated in our
study.
The CDR consists of seven scores, which describe the capability of patients to handle
their daily life. It delivers scores for memory, orientation, judgment, community, activities,
personal care, and a global score. Possible values for the scores are 0, 0.5, 1, 2 or 3, where 0
is the best result.
For the CDT, the patient has to draw a clock which shows ten past eleven. The patient is
graded in a range from one to six, depending on how well the clock is drawn, and if it shows
the correct time. A score of one reflects the perfect clock.
3 Method
The data mining part of our approach is illustrated on the right-hand side of Fig. 1. In the
first step, we apply k-Medoids clustering to the image data. The clusters of the best clus-
terings according to clustering quality and expert evaluation are further interpreted by the
corresponding non-image data. For the interpretation of image clusters, we employ rela-
tional subgroup discovery (RSD) [10,17], an algorithm for finding interesting subgroups in
data. In subgroup discovery, the goal is to find subgroup descriptions (typically conjunc-
tions of attribute values as in rule learning) for which the distribution of examples with
respect to a specified target variable is “unusual” compared to the overall target distribu-
tion. In our case, clinical and demographic variables form the subgroup descriptions, and the
cluster membership is chosen as the target variable. Before applying RSD, we still remove
images with incomplete corresponding non-image data as well as all clusters below a certain
size.
In the following, we give a short description of the clustering and subgroup discovery
algorithms and explain how we applied them to our data.
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Fig. 3 Distribution of variance (over all patients) of voxels from the 32nd layer of the PET scans
3.1 Clustering
We chose the k-Medoids algorithm [9], a derivate of k-Means [20], with variance-weighted
features to cluster PET scans. Alternative clustering approaches and their results will be
discussed in Sect. 6. As mentioned earlier, the images have to be normalized and standard-
ized before clustering. The resulting ASCII files (with over 500,000 real-valued entries) were
taken as input for k-Medoids. To obtain meaningful and significant clusters using k-Medoids,
it is necessary to weight the features according to their variance. This is feasible due to the
huge differences in the variance of the intensity in different brain regions. These differences
are caused, among others, by activation patterns specific for certain types of dementia and
for healthy controls. Moreover, it is clear that not all parts of a PET scan reflect the state of
brain tissue: For instance, in the PET image, the brain is surrounded by a dark area which is
the same for all scans (cf. Fig. 2). Figure 3 shows the variance distribution of the voxels in
the 32nd layer over all PET scans. As regions of low variance are not very informative for
the clustering, we chose to weight each voxel at position (i, j, k) by the standard deviation
over all PET scans si jk . Therefore, we obtain the following distance measure based on the
Euclidian distance measure with the variables weighted by their standard deviation:
dist(A, B) =
√
√
√
√
n
∑
i=1
m
∑
j=1
l
∑
k=1
(si jk · ai jk − si jk · bi jk)2 (1)
Since the optimal number k of clusters is not known in advance, we need a quality measure
to compare clusterings with different k. One of the few quality measures for clusterings
independent of k is the silhouette coefficient (SC) [9]. For a single cluster C of a clustering
C it is defined as
SCC (C) = 1|C |
∑
x∈C
b(x, C) − a(x, C)
max {a(x, C), b(x, C)} (2)
where a(x, C) is the distance of object x to the medoid of the cluster C it belongs to and
b(x, C) the distance of object x to second nearest medoid. For an entire clustering Ck we used
the mean of SCC (Ck) over all C which is referred to as SC(Ck) in the following.
It always holds −1 ≤ SC ≤ 1. A high SC does not necessarily reflect the best clustering,
since SC(Ck) = 1 for all Ck with k = 1 or k = |X |. Generally, SC(Ck) increases with
k → |X |, because SCC (Ck) = 1 for all clusters C that consist of one example only.
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On our data, clustering with more than 30 clusters results in too small clusters despite
their high SCs. Clustering with k < 10 is not informative as well, because it tends to find
results consisting of two or three very large clusters and single outliers forming their own
clusters. In this case, the resulting SC(C) is high because outliers forming their own clusters
have an SC of 1, which increases the overall SC . Therefore, the number of appropriate k was
expected to be between 10 and 30.
As the results of k-Medoids depend both on the initial choice of medoids and the input
order of objects, it was tested 5,000 times for each k ∈ 2, . . . , 100, and the clustering C∗k
with the maximum SC was chosen. The initial computation of the distance matrix needed 2
hours, and the 5,000 runs took 2 hours for all k on a 1 GB RAM (1.6 GHz) machine.
For the obtained SC distribution, local maxima exist at k = 10, 12, and 16. We hence,
chose to further examine these three clusterings using subgroup discovery on the corre-
sponding clinical and demographic data. Since our analysis showed very similar results for
clustering with k = 12 and k = 10, we omit the presentation of the results for k = 12, and
focus on only those for k = 10 and k = 16 in Sect. 4.
To determine the significance of a clustering with parameter k, an additional randomi-
zation test was performed. All original scans were shuffled to obtain 454 new images in a
way that each voxel occurred again in one of the new scans, while keeping its location. So,
the variance for each voxel stays the same. Subsequently, a clustering for parameter k was
performed 100 times similarly to the original clustering. The resulting SCs were used to
create a sorted list. For a given clustering Ck with original data, the p-value can easily be
determined by the rank of the corresponding silhouette coefficient SC(Ck) in this list. The
final validation of the clustering is done by presenting the mean images to an expert, who
interpreted them and explained details.
3.2 Subgroup discovery
Subgroup Discovery (SD) is a method for finding subgroups in a dataset that are sufficiently
large and statistically unusual given their distribution on an attribute of interest. In this work,
we used the subgroup discovery algorithm RSD and its publicly available Prolog implemen-
tation3 [16].
The RSD algorithm is a modification of the CN2 rule learner [5] to find subgroups in a
relational dataset. The difficulty of applying a common rule learner to this task is that its cov-
ering algorithm is not designed for finding subgroups. It does not take into account examples
as soon as they are covered by a rule. This implies that rules discovered in a later iteration are
built on a smaller and thus biased subset of examples. Therefore, only the first few rules found
by a rule learner are appropriate for subgroup discovery, i.e., they have a sufficiently large
coverage. To overcome this problem, RSD assigns the weight 1i+1 to each example, where
i is the number of rules (subgroup descriptions) covering the example. Initially, the weight
of each example is set to one. Whenever a rule is found, the weight is decreased for each
covered example. To find large and interesting rules even in later iterations, RSD uses the
modified weighted relative accuracy (mW R Acc) heuristic. For a subgroup with description
Cond and target variable Class, it is defined as
mW R Acc(Class ← Cond) = n
′(Cond)
N ′
·
(
n′(Class.Cond)
n′(Cond)
− n(Class)
N
)
(3)
3 http://labe.felk.cvut.cz/~zelezny/rsd/.
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where N is the number of examples, n(Class) is the number of examples in Class, N ′ is the
sum of weights of all examples, n′(Cond) is the sum of weights of examples covered by the
subgroup, and n′(Class.Cond) is the sum of weights of examples that are covered by the
subgroup and actually fall into the class. mW R ACC tends to find rules for examples that are
least frequently covered by previously discovered rules. Furthermore, mW R ACC ensures a
balance between generality and relative accuracy. This results in shorter rules which are thus
easier to comprehend compared to the outcome of a rule induction algorithm.
The parameters of RSD were set as follows: For getting the maximal number of interesting
subgroups for each class, the output was increased to 20 subgroups for each class. The beam
width was set to 15, and the maximal number of literals in each rule was set to 4. For the
clustering results with k = 16, the running time of RSD on a Pentium 4 (2,8 GHz) with 1 GB
RAM was approximately 8 hours.
To determine the significance of a subgroup (Class ← Condi ), the following likelihood
ratio score [8] is used:
Sig(Class ← Condi ) = 2 ·
k
∑
j=1
n(Class j .Condi ) · log n(Class j .Condi )
n(Class j ) · p(Condi ) (4)
It shows how significantly different the class distribution in a subgroup is from the prior
class distribution. The significance can be used to estimate the p-value, which indicates the
statistical significance of the rule. It is calculated from the χ2-distribution with k −1 degrees
of freedom (k=number of clusters). As usual, a subgroup is considered significant, if its p-
value is below 0.05. Interesting rules were identified by checking their p-value and by expert
validation.
4 Results
This section focuses on the clusterings C∗10 and C∗16. First, we present the medical interpre-
tation of the mean images of the obtained clusters in Sect. 4.1. Subsequently, we discuss in
Sects. 4.2–4.4 the characteristics of clinical values and subgroup results from RSD with the
clusters from the clusterings with k = 10 and k = 16 as the target variable. Moreover, we
relate the subgroup descriptions to medical expert knowledge.
4.1 Clustering of PET scans
Both clusterings (with k = 10 and k = 16) were significant with a p-value less than 0.01 as
determined by the randomization test. Generally, the clusters vary widely in their size and also
encompass singleton clusters, i.e., outliers. More specifically, the distribution of cluster sizes
for clustering C∗10 is (187, 2, 5, 2, 4, 1, 5, 1, 207, 40), meaning that the first cluster consists
of 187 PETs, the second of 2, and so forth. In the following, we refer to the first cluster in this
list as Cluster 0, and the i th as Cluster i −1. Analogously, the distribution of cluster sizes for
clustering C∗16 is (2, 42, 1, 8, 105, 104, 28, 40, 8, 1, 3, 61, 1, 1, 48, 1). Thus, both clusterings
found outliers and other very small clusters. In fact, one image that was sorted into its own
cluster was rotated upside down. It was therefore most different from all other scans. The
other singletons scans were strongly deformed, for which SPM5 is unable to compensate.
For instance, some patients kept their chin too close to the chest during the recording.
For all clusters containing at least five PETs, we calculated their mean images (five for
clustering with k = 10, and nine for clustering with k = 16). In both clusterings, we found
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Fig. 4 Mean images of the three largest clusters of the clustering with k = 10
Fig. 5 Mean images of the nine largest clusters of the clustering with k = 16. In the second row on the right
is the mean image of the healthy control group C
clusters grouping patients with frontotemporal dementia (Cluster 9 in Fig. 4 and Cluster 7
in Fig. 5), nearly healthy patients (Cluster 0 in Fig. 4 and Cluster 4 in Fig. 5) and global
hypometabolism (Cluster 3 in Fig. 5 and Cluster 2 of C∗10 not illustrated). Clustering with
k = 16 performed better, because it managed to differentiate more precisely the group of
left lateral deficiency (Cluster 8 in Fig. 5) and a typical Alzheimer’s cluster (Cluster 11 of
size 61 in Fig. 5). Both were not separated by the clustering with k = 10. Even though the
remaining clusters cannot be interpreted clearly from a medical point of view, they can be
distinguished visually. This can be seen by the differences in metabolism in the occipital and
centering regions, which are lighter in Cluster 5 than in Cluster 6 (Fig. 5). Cluster 1 shows
highly affected patients.
In summary, the clusterings were judged as meaningful by domain experts (R. Perneczky
and A. Drzezga). To further explain the differences in the cognitive areas, we combined
the images with clinical data. In the next section, we present a simple correlation analysis
and relate the clusters to single non-image variables. This serves as a baseline for the more
complex approach based on subgroup discovery.
4.2 Simple correlation analysis of C∗16
In medicine, next to the diagnosis and test results, age and gender are important variables to
describe status and progression of a disease. Therefore, we first relate the large clusters of
C∗16 to those attributes. Looking at the distributions of diagnoses of C∗16, some clusters have a
high proportion of patients with Alzheimer’s disease, while others contain only patients with
123
158 J. Schmidt et al.
Fig. 6 Distribution of ICD10 codes for clusters of C∗16
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Fig. 7 Distribution of the MMSE score for clusters of C∗16
a cognitive disorder (Fig. 6 clusters 4 and 11). This indicates that k-Medoids clustering is
capable of grouping similar images together. This is also supported by the MMSE values of
the clusters (Fig. 7). Cluster 4 has the highest MMSE score and a low variance, indicating that
its patients are almost healthy. In contrast, the MMSE of Cluster 14 is not bad (around 25),
but the high variance indicates that there exist some patients that suffer from a more severe
disease. The same is true for clusters 8, 11, and 1. This is an interesting finding, because it
states that patients with a similar brain metabolism may have different cognitive abilities.
Cluster 8 comprises patients who have a left-lateral metabolic deficiency, so the low MMSE
score can be explained well. Again, the high-variation states that there are some patients in
Cluster 8 that can compensate the hypermetabolism and still have a good cognitive ability
yielding good test results.
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Fig. 8 Distribution of age for clusters of C∗16
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Fig. 9 Distribution of males/females for clusters of C∗16
As age is correlated with the progress of dementia, we also investigated the distribution of
age among the clusters (Fig. 8). The difference between Cluster 14 and Cluster 4 is approx-
imately 20 years. The average age of Cluster 14 is around 75 while Cluster 4 has younger
people of age 55, which goes hand in hand with the distribution of ICD10 codes that define
Cluster 4 as an almost healthy cluster. Cluster 3 also has a very high average age and a low
variance characterizing old morbid people with an advanced hypometabolism.
Concerning the gender distribution of each cluster, Clusters 4 and 14 have a higher fraction
of women, while Cluster 11 holds more men (Fig. 9). This is quite interesting, because it
suggests that there might be some differences in the development of dementia between the
genders. Another explanation may be a different behavior as to when a physician is consulted.
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Table 1 Interesting subgroups in Cluster 0 of C∗10
Id. Description p-value |sg∩cl||cl|
|sg∩cl|
|sg| Class distr.
A1 Age ≤ 54 <10−4 0.25 0.85 (29,5,0)
A2 Verbal fluency ≥ 20 7 × 10−3 0.22 0.64 (25,11,0)
A4 ICD = Alzheimer’s 5 × 10−2 0.13 0.7 (14,6,0)
& Age: 65–69
A9 MMST: 26–29 2 × 10−2 0.05 1 (6,0,0)
& BNT: 14–15
& ICD = F06.7
& Age: 55–59
A11 Activities = 1 5 × 10−2 0.04 1 (4,0,0)
& Constructional praxis: 3–5
Overall distribution over clusters 0, 8, 9: (115,118,14)
|sg∩cl|
|sg| is the proportion of patients in the subgroup sg having a PET in cluster cl. In contrast,
|sg∩cl|
|cl| expresses
the proportion of the patients with a PET in cluster cl that are also covered by the subgroup description of sg
Bold numbers refer to the cluster described by the subgroups. Each number states the number of patients in
the cluster covered by the particular subgroup. Numbers in the last row present the total number of patients in
the clusters
This first overview of attributes in the clusters shows their general characteristics. How-
ever, simple correlation analysis is not able to detect dependencies among the attributes.
Clearly, the correlation of multiple attributes can only be analyzed by more complex meth-
ods like subgroup discovery. It allows us to explore the interaction of attributes within a
cluster. For instance, Cluster 14 has a high variance in MMSE scores and an unbalanced
gender distribution, but so far we cannot see if men have a better MMSE score than women,
or if there is no significant difference between the genders. Identifying subgroups helps
to combine interesting characteristics and allows to take into account several variables at
once.
4.3 Subgroup discovery on C∗10
Our application of subgroup mining requires reliable psychological data and sufficiently large
clusters. Thus, we first discard those examples without revised psychological data. Next, we
eliminate all clusters with less than five examples after the first filtering step. Thus, we keep
Cluster 0, Cluster 8, and Cluster 9, with the sample distribution (115, 118, 14) [initially, it
was (187, 207, 40)]. Figure 4 shows the mean images for each of these clusters.
Table 1 displays the interesting subgroups discovered for Cluster 0. Each row in the table
presents a subgroup description along with quality measures and the distribution of cases
over the clusters. For instance, the first subgroup A1 covers 29 images from Cluster 0, 5
images from Cluster 8, and none from Cluster 9.
The mean image of Cluster 0 resembles the 20 healthy controls (Fig. 2), which leads
to the assumption that this cluster contains mainly almost healthy patients. Subgroup A1
shows that 85% of the patients, younger than 55, fall into Cluster 0. Experts confirm that the
younger a patient, the better the activity of metabolism and the lower the probability of a
dementia diagnosis. Furthermore, subgroup A2 and A9 reveal that the distribution of patients
with good test results is especially high in Cluster 0, which also explains the similarity of
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Table 2 Interesting subgroups in Cluster 9 of C∗10
Id. Description p-value |sg∩cl||cl|
|sg∩cl|
|sg| Class distr.
A41 Constructional praxis: 10–11 4 × 10−3 0.57 0.22 (14,14,8)
& Gender: m
& ICD: other diag.
A42 Memory: 1 2 × 10−3 0.29 0.5 (3,1,4)
& Activities: 1
& Judgment: 0–0.5
& Community: 1
A49 Community: 2–3 2 × 10−3 0.29 0.4 (1,5,4)
A52 CDT: ≤ 2 2 × 10−4 0.21 1 (0,0,3)
& word list recall: 10
& verbal fluency: 9–12
& other tests: CT
A53 CDT: 3–6 2 × 10−3 0.21 0.6 (0,2,3)
& global: 2–3
& community: 2–3
A55 gender: m 2 × 10−4 0.21 1 (0,0,3)
& verbal fluency: 0–8
& community: 2–3
Overall distribution over clusters 0, 8, 9: (115,118,14)
Bold numbers refer to the cluster described by the subgroups. Each number states the number of patients in
the cluster covered by the particular subgroup. Numbers in the last row present the total number of patients in
the clusters
the mean image to the healthy controls. Hence, these subgroups confirm the assumption that
Cluster 0 contains the healthier patients.
However, there is also one subgroup of patients with Alzheimer’s diagnosis (A4) and
one describing patients with a very low score for CDR activities and CERAD constructional
praxis (A11). Further research revealed that these people suffer from Alzheimer’s disease in
an advanced state, which should not fall into this cluster. The corresponding mean images of
the outliers in this cluster had the most affinity to Cluster 0 in high-variance areas. With the
choice of a larger k, the algorithm can sort them out into different clusters. We can conclude
that the subgroup mining step identifies four outliers within Cluster 0.
Cluster 9 (in Fig. 4) describes patients that have a huge deficit in the frontotemporal
metabolism. This leads to the conclusion that they are not affected by Alzheimer’s disease,
but by some other form of dementia. Furthermore, experts assumed no significant reduction of
CERAD constructional praxis (A41), while CERAD verbal fluency is highly impaired (A55)
as well as scores in CDR (A42). These conclusions could be confirmed by the subgroups in
Table 2.
The discovered subgroups for Cluster 8 showed that it consists mainly of patients above
the age of 74. However, for a medical interpretation of this cluster, the medical experts could
not obtain additional information from the mean image or the other subgroup descriptions.
Thus, we assume that this cluster is too heterogeneous and that we need a clustering with a
larger k to split this cluster into smaller, more homogeneous clusters.
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Table 3 Interesting subgroups in Cluster 4 of C∗16
Id. Description p-value |sg∩cl||cl|
|sg∩cl|
|sg| Class distr.
A21 BNT: 14–15 2 × 10−4 0.6 0.56 (4,40,13,1,3,6,5)
& CDT: 1–2
A22 Age: 0–54 <10−4 0.39 0.79 (3,27,1,0,0,2,1)
A23 Word list recall no: 10 < 10−4 0.42 0.7 (1,29,5,0,0,0,2)
& CERAD-sum:
76–100
A24 Constructional praxis: 10–11 <10−4 0.42 0.78 (1,29,7,0,1,0,3)
& Constructional praxis recall:10–11
A26 BNT: 14–15 < 10−4 0.33 0.89 (0,23,3,0,0,0,0)
& MMSE: 26–29
& Verbal fluency: ≥ 20
Overall distr. over clusters 1, 4, 5, 6, 7, 11, 14: (22,69,58,17,13,37,29)
Bold numbers refer to the cluster described by the subgroups. Each number states the number of patients in
the cluster covered by the particular subgroup. Numbers in the last row present the total number of patients in
the clusters
4.4 Subgroup discovery on C∗16
Analogously to the filtering procedure for C∗10, we only kept seven clusters for the further
analysis of C∗16: Clusters 1, 4, 5, 6, 7, 11, and 14, containing (22, 69, 58, 17, 13, 37, 29) images
[initially (42, 105, 104, 28, 40, 61, 48)]. Figure 5 shows those clusters and those having more
than five images before the filtering steps (Cluster 3 and Cluster 8).
In this clustering, we find a cluster (Cluster 4) that resembles the mean image of the healthy
controls. Since no hypometabolism is visible, medical experts interpreted it as representing a
group of almost healthy patients. Table 3 shows a subset of the interesting subgroups discov-
ered for Cluster 4. Groups of young patients (A22) and groups of patients with very good test
results (A21, A23) were discovered. So, the clustering identified a relatively healthy group
that was supported by both subgroup discovery and experts.
Cluster 7 describes patients that have a huge deficit in the frontotemporal metabolism.
This leads to the conclusion that they are not affected by Alzheimer’s disease, but by some
other form of dementia. Furthermore, experts assumed no significant reduction of CERAD
constructional praxis, while CERAD verbal fluency is highly impaired as well as scores in
CDR. Significant subgroups that show the impairment were found for clustering with k = 16
and k = 10.
The mean image of Cluster 11 is the prototype of a patient with Alzheimer’s disease,
which is confirmed by the subgroups displayed in Table 4. 78.4% of the patients in this clus-
ter have the disease, which is visible in the mean image through the reduction of metabolism
in the temporoparietal cortex. In fact, this is not the only cluster with a high ratio of patients
with Alzheimer’s disease. In Cluster 6, 70% of the patients suffer from the disease. This
was confirmed by subgroups containing an Alzheimer’s diagnosis. Contrary to Cluster 11, in
Cluster 6 also the frontal metabolism is reduced. This is reflected by worse (higher) results
of CDR.
Regarding the subgroups found for Cluster 14 (Table 5), it seems that this cluster describes
elderly women (A124, A129, A133) with low test results and therefore a similar state of
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Table 4 Interesting subgroups in Cluster 11 of C∗16
Id. Description p-value |sg∩cl||cl|
|sg∩cl|
|sg| Class distr.
A101 ICD: Alzheimer’s < 10−4 0.78 0.33 (11,5,16,12,3,29,13)
A102 BNT: 14–15 < 10−4 0.32 0.71 (0,0,3,1,1,12,0)
& gender: m
& ICD: Alzheimer’s
A106 age: 55–59 5 × 10−4 0.19 0.58 (1,1,0,3,0,7,0)
& ICD: Alzheimer’s
A107 age: 65–69 10−4 0.3 0.58 (3,1,3,1,0,11,0)
& ICD: Alzheimer’s
Overall distr. over clusters 1, 4, 5, 6, 7, 11, 14: (22,69,58,17,13,37,29)
Bold numbers refer to the cluster described by the subgroups. Each number states the number of patients in
the cluster covered by the particular subgroup. Numbers in the last row present the total number of patients in
the clusters
Table 5 Interesting subgroups in Cluster 14 of C∗16
Id. Description p-value |sg∩cl||cl|
|sg∩cl|
|sg| Class distr.
A121 Graduation < high school 2 × 10−1 0.52 0.24 (4,17,15,3,1,8,15)
& Gender: f
A124 ICD: Alzheimer’s 2 × 10−3 0.17 0.83 (0,0,0,1,0,0,5)
& Personal: 0–0.5
& Gender: f
& Age: 70–73
A126 wordlist recall: 7–10 2 × 10−1 0.07 1 (0,0,0,0,0,0,2)
& Gender: m
& Age: 65–69
& MMSE: 30
A127 other tests: MR 7 × 10−3 0.24 0.54 (1,1,3,1,0,0,7)
& Graduation
< high school
& Age: 74–77
A129 Gender: f 10−2 0.17 0.71 (0,0,1,0,0,1,5)
& MMSE: 11–20
& Age: 70–73
A133 Gender: f 10−2 0.14 1 (0,0,0,0,0,0,4)
& CERAD-sum: 47–57
& Age: ≥ 78
Overall distr. over clusters 1, 4, 5, 6, 7, 11, 14: (22,69,58,17,13,37,29)
Bold numbers refer to the cluster described by the subgroups. Each number states the number of patients in
the cluster covered by the particular subgroup. Numbers in the last row present the total number of patients in
the clusters
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Table 6 Comparison of the
gender distribution in Cluster 14
of C∗16
Women (n) Men (n)
Age 75 (19) 70 (10)
MMSE 23.26 (19) 25.22 (9)
global 0.97 (15) 0.8 (5)
CERAD-Sum 53.64 (14) 62.5 (8)
CDT 3.93 (15) 3.66 (9)
dementia. Surprisingly, there is a group of men with high-MMSE scores (A126). Although
this subgroup is not significant, it is highly interesting. It indicates that men with the
same metabolic patterns as women have a less impaired cognitive ability. Further inves-
tigations (Table 6) showed that men and women are in the same age group, but men do have
slightly better overall results in the most important psychological tests. Although female
and male patients fall into the same cluster (based on brain metabolism), they apparently
differ in their cognitive abilities. This finding may possibly be explained by the hypothesis of
cognitive reserve, which postulates that some individuals can somehow offset the symptoms
of neurodegeneration. Although the neurobiological substrate is still unknown, the higher
neuron count in men might be associated with higher reserve. To show the same symptoms of
dementia as women, men have to suffer from a larger loss of cells. Another factor discussed
in dementia research [14] is the education level, which is also higher among the men in this
cluster, compared to the women. Here we now see an example of the power of subgroups.
The method allows not only to describe sets of instances, but also to bring up groups with
unusual and therefore interesting features, which cannot be found by simple correlation stud-
ies. Altogether, we can conclude that the clustering with k = 16 produces more meaningful
clusters than the clustering with k = 10. Even though all subgroups displayed are statistically
significant (see the p-values), C∗16 differentiates more accurately. For example, it detects an
“Alzheimer cluster” (Cluster 11), whereas the distribution of patients with Alzheimer’s dis-
ease in C∗10 is (39, 48, 5). Therefore, none of the clusters in C∗10 shows a preference of being
a definite “Alzheimer cluster”.
5 Comparison with constrained clustering
Another possible approach is to apply methods from constraint-based clustering (e.g., by
Sese et al. [15]), such that only clusters constrained by descriptions of non-image variables
are considered. This is similar to the usual approach in medicine: select a subset of patients
fulfilling specific predefined criteria and compare the images associated with those patients.
Automating this process results in determining frequent itemsets based on the structured
non-image data. This can easily be achieved with the Apriori algorithm [20]. First, we select
a subset of patients covered by one frequent itemset. Then we evaluate the similarity of their
PET scans by the mean of the pairwise weighted Euclidean distance. In this way, we obtain
a mean distance for each itemset.
The gray diamonds in Fig. 10 represent the discovered itemsets, where the x-axis corre-
sponds to their mean distance and the y-axis to the size of the subset covered by the itemset.
We found 5,858 frequent itemsets for a minsupport of 0.1. For comparison, the white squares
represent the large clusters from clustering C∗16. We can see that Cluster 4 (similar to healthy
controls) has a lower mean distance (higher similarity of brain activity) than any of the item-
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Fig. 10 Mean within-cluster distance (x-axis) and support (y-axis) of resulting itemsets (clusters) with a
minimum relative support of 0.1
set constraint groups. However, there is a large number of itemsets with more homogeneous
PET scans than Cluster 11 and Cluster 7. This is a result of the clustering approach, where the
task is to find a set of disjoint clusters whose union covers the entire example set. Therefore,
it is necessary to also put patients with dissimilar PET scans into a cluster.
The clustering task constrained by itemsets means finding a set of disjoint frequent item-
sets that together cover all examples. We do that in a greedy way: we determine the itemset
with the most homogeneous PET scans. Then we determine the next most homogeneous
itemset which does not overlap with the previously determined itemsets and so on. When no
more disjoint itemset can be found, we combine the yet uncovered, remaining examples into
a final set. The black triangles in Fig. 10 represent the set of disjoint itemsets. It shows that
two of the disjoint itemsets have higher mean distance than the clusters in clustering C∗16.
In summary, we can say that itemset-constrained clustering provides physicians with
groups of patients that share similar psychological and similar metabolic patterns (itemsets
with low mean distance). Additionally, it finds groups with similar psychological patterns and
high variation in brain activity (itemsets with high mean distance). However, this approach
is not able to detect a complete set of patients with similar brain activity. On the other hand,
clustering of PET scans finds groups of patients with similar brain activity. That means our
approach can combine all patients with a particular metabolic pattern, even patients that differ
in their psychological features. Moreover, we automatically create an overview of the status
of disease and provide hypotheses to be further validated by medical experts.
6 Discussion
As they reflect, in some sense, the “ground truth” of the state of a brain, we chose PET
images as the starting point of our analysis. The differences between different states are
then explained by non-image variables. The presented approach uses k-Medoids and RSD
to achieve those tasks, but we also considered and tested other methods for clustering and
correlation analysis. Due to the high dimensionality of the data, we also tested the sub-
space clustering method PreDeCon [2], but could not identify appropriate parameter settings
to obtain significant results. As a further test, we clustered the images with hierarchical
agglomerative clustering (complete linkage). This method also found the outliers mentioned
above and sorted the relatively healthy patients into one cluster. However, although the two
clustering methods produced largely similar results, they differed in the partition of unspecific
clusters, which may be explained by the “myopia” of the hierarchical clustering scheme. To
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establish a baseline for the subgroup discovery, we performed a simple correlation analysis
based on individual variables. Our experiments confirmed that this is clearly not sufficient,
as many of the more complex subgroups cannot be detected in this way.
From a medical point of view, we showed that it is possible to obtain meaningful clus-
ters of PET scan images. Medical experts could identify different patterns of disease, and
confirmed that the resulting findings (clusters, outliers and subgroups) have medical novelty
and significance. As mentioned above, the new approach of reversing the direction of the
analysis, i.e., starting with the PET scan images, is considered new in this area.
7 Related work
Data mining in the context of dementia and Alzheimer’s disease can be roughly categorized
into three categories: First, machine learning approaches for the improvement of differential
diagnosis. Second, data mining techniques applied to brain imaging data. Third, transcripto-
mics and proteomics analysis of dementia and Alzheimer’s disease.
One of the earliest work from the first category deals with the prediction of the type of
dementia (Alzheimer’s disease, vascular dementia, or other) from a small set of demographic
variables and the total scores from clinical tests [11]. The latter variables included measures
of category fluency, letter fluency, delayed free recall and recognition, simple and complex
attention span, visual-constructional abilities, and object naming. Similarly, Corani et al.
[6] predicted different types of dementia (Alzheimer’s disease, dementia with Lewy bodies,
Parkinson’s disease with dementia and vascular dementia) from cognitive profiles based on
the Cognitive Drug Research (CoDR) system. CoDR consists of a series of computerized
tests (tasks), which assess some cognitive faculties of the patient, such as memory, attention,
and reaction times. The results from those tests together constitute the cognitive profile of a
patient.
Work from the second category includes the one by Fung and Stoeckel [7] and Megalo-
oikonomou et al. [12]. Fung and Stoeckel [7] classify Alzheimer’s patients based on their
SPECT images. Megalooikonomou et al. [12] give a survey of data mining techniques applied
to brain imaging data. Clustering is applied to find groups of inter-related voxels, not to find
groups of images. To the best of our knowledge, clustering methods have not been applied
to whole PET scans before.
The third category includes a study of gene expression changes in patients with
Alzheimer’s disease [18] and a study aiming for the discovery of Alzheimer-relevant pro-
teins [4].
The work presented in this paper differs from previous work in its combined analysis of
PET images and clinical variables. Similar to work in the first category, the results are mainly
useful for diagnostic purposes. Although biological information in the form of transcripto-
mics or proteomics data is not yet used in our approach, it is easy to incorporate it in the
subgroup descriptions or even as the target for subgroup discovery.
8 Conclusion
In the paper, we introduced a new and challenging problem for data mining research: cor-
relating large databases of PET scans with structured patient data. The goal of the work
was not to develop completely new methods, but to show that current data mining methods
like RSD are able to solve this large (initially 200 GB) and complex (image data and 11
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relations) problem and produce valid and relevant results. The task itself is critical to gain a
better understanding of various forms of dementia. The presented approach aims for more
completeness than previous methods. To do so, we first identified clusters of PET scans shar-
ing similar features in brain metabolism. In the second step, we explained the differences
and commonalities among those clusters in terms of clinical and demographic variables. To
validate the results, we computed p-values of the clusterings and interpreted the clusters and
subgroup descriptions in the light of domain knowledge. To the best of knowledge, this type
of analysis has not been done before. One of the subproblems, the clustering of whole PET
scans (not voxels), also has not been addressed in the literature before.
In future work, we are planning to further improve the quality of the clusterings by taking
into account more advanced features (e.g., brain regions) and by developing more advanced
methods specifically for high-dimensional PET images. Moreover, standard algorithms for
subgroup discovery suffer from similar problems as algorithms for pattern mining and asso-
ciation rule mining [13]. For instance, it is necessary to filter interdependent results, as
the refinement (specialization) of an “interesting” subgroup is likely to produce another
“interesting” subgroup. Another limiting factor of the subgroup discovery approach is the
incompleteness of the psychological data. Finally, the integration of gene expression and
proteomic data could aid in the formation of mechanistic hypotheses.
In summary, we believe that explaining medical images in terms of other variables (patient
records, demographic information, etc.) is a challenging new and rewarding task for data min-
ing research.
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